Portable Bioprocessing Bioreactors Market 2028 By Capacity, Material, Control Type, End User and Geography | The Insight Partners

report image

Portable Bioprocessing Bioreactors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Capacity (1-10L, 10-50L, 50-100L, 100-500L); Material (Glass, Stainless Steel, Single-Use); Control Type (Automate, Manual); End User (Biopharmaceuticals Industry, Academic Institute, Research Laboratories) and Geography

Report Code: TIPRE00024866 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


The portable bioprocessing bioreactors are the devices that imitate a natural biochemical environment in the laboratories for the optimum cells or tissues growth in microbial & cell culture. It provides control over various parameters such as temperature, moisture, pH, oxygen, and the stirring rate to produce the most satisfactory results like maximizing cell growth and productivity. The main objective of portable bioprocessing bioreactor is to reduce the complex steps that occur in traditional bioprocessing bioreactors. It is a compact, user-friendly and automated device that requires small space to fit in.


The "Global Portable Bioprocessing Bioreactors Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the portable bioprocessing bioreactors market with detailed market segmentation by capacity, material, control type, end user, and geography. The report provides key statistics on the market status of the leading portable bioprocessing bioreactors market players and offers key trends and opportunities in the market.


  •  Based on capacity, the global portable bioprocessing bioreactors market is segmented into 1-10L, 10-50L, 50-100L and 100-500L.
  •  Based on material, the market is segmented into glass, stainless steel and single-use.
  •  On the basis of control type, the market is bifurcated into automated and manual.
  •  On the basis of end-users, the market is bifurcated into biopharmaceuticals industry, academic institute and research laboratories.


  •  Growing development of the biopharmaceuticals research and industry areas.
  •  Rise in demand for bioreactors having high-efficiency and less floor space requirement.
  •  Technological advancements in bioreactors.


  •  Unavailability of skilled professionals.
  •  Requirement of the high maintenance of the portable bioprocessing bioreactors.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The portable bioprocessing bioreactors market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the portable bioprocessing bioreactors market in these regions.


COVID-19 initially began in Wuhan (China) in December 2019, and till now, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. With the rising pandemic, many biopharmaceutical companies are involved in developing vaccines in response to it. In the medical sector, bioreactors are in high demand. This generates lucrative opportunities for companies engaged in this domain. A decrease in the pharmaceutical R&D expenditure and a drop in biologics sales in 2020 due to the lockdown and business shutdown significantly impacted the growth of the portable bioprocessing bioreactors market. However, the surge in vaccine R&D has increased the demand for bioprocessing technologies. Hence, owing to the factors mentioned above, the healthcare industry and bioprocessing manufacturing industries are affected positively in terms of growth, and the overall market will witness substantial growth in the forecast period.

Get more information on this report :


The report covers key developments in the portable bioprocessing bioreactors market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from portable bioprocessing bioreactors market are anticipated to have lucrative growth opportunities in the future with the rising demand for portable bioprocessing bioreactors in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the portable bioprocessing bioreactors market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Merck & Co. Inc.
  •  Thermo Fisher Scientific Inc.
  •  GE Healthcare
  •  Sartorius Stedim Biotech SA
  •  Cesco Bioengineering Co., Ltd.
  •  Eppendorf AG
  •  Biosan Laboratories, Inc.
  •  IKA laboratory
  •  Cellexus Ltd.
  •  Solaris Biotech Company
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Merck and Co. Inc.
2. Thermo Fisher Scientific Inc.
3. GE Healthcare
4. Sartorius Stedim Biotech SA
5. Cesco Bioengineering Co., Ltd.
6. Eppendorf AG
7. Biosan Laboratories, Inc.
8. IKA laboratory
9. Cellexus Ltd.
10. Solaris Biotech Company
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount